Gastric Cancer

• CLINICAL_TRIALS trial_result · 2022-09-13
  Clinical Trial Update: Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors [Phase 1, Phase 2]

  A Phase 1/2 trial evaluating a CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, with stated gastric, colon, rectal, esopha…

• CLINICAL_TRIALS trial_result · 2022-09-10
  Clinical Trial Update: Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer [Phase 1, Phase 2]

  Phase Ib/II study evaluating nivolumab with paclitaxel in EBV-related or MSI-H or PD-L1 positive advanced gastric cancer has completed.

• CLINICAL_TRIALS trial_result · 2022-09-08
  Clinical Trial Update: Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ Andenocarinoma [Phase 2]

  Phase 2 trial update for Cinrebafusp Alfa combined with ramucirumab and paclitaxel in HER2-high gastric/GEJ adenocarcinoma, and Cinrebafusp …

• CLINICAL_TRIALS trial_result · 2022-09-06
  Clinical Trial Update: Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors [Phase 2]

  Phase 2 trial evaluating surufatinib combined with sintilimab and SCRT in various unresectable advanced solid tumors, including biliary trac…

• CLINICAL_TRIALS trial_result · 2022-09-06
  Clinical Trial Update: Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma [Phase 2]

  Phase 2 clinical trial investigating tirelizumab in combination with chemoradiation for unresectable locally advanced gastric cancer or gast…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-08-29
  Clinical Trial Update: Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer [Phase 2]

  Exploratory Phase 2 clinical study assessing Penpulimab combined with SOX as perioperative treatment for gastric cancer.

• CLINICAL_TRIALS trial_result · 2022-08-26
  Clinical Trial Update: PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery [Phase 2]

  A Phase 2 clinical trial update evaluating a PD-1 antibody as adjuvant therapy for gastric cancer patients with MSI-H following D2 radical s…

• CLINICAL_TRIALS trial_result · 2022-08-25
  Clinical Trial Update: Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery [Phase 1, Phase 2]

  A Phase 1/2 study evaluating pembrolizumab with chemotherapy and radiation before surgery for locally advanced gastroesophageal junction or …

• CLINICAL_TRIALS trial_result · 2022-08-18
  Clinical Trial Update: Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]

  A phase 1/2 trial evaluating Fruquintinib with Toripalimab and SOX chemotherapy as first-line treatment for advanced/metastatic gastric or g…

• CLINICAL_TRIALS trial_result · 2022-08-18
  Clinical Trial Update: A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers [Phase 1, Phase 2]

  Phase 1/2 safety and activity study of SBT6050 in combination with other HER2-directed therapies for HER2-positive cancers; the trial status…

• CLINICAL_TRIALS trial_result · 2022-08-17
  Clinical Trial Update: Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer [Phase 2]

  Phase 2 clinical trial update on preoperative chemotherapy strategy for locally advanced gastric/gastroesophageal cancer; study completed.

• CLINICAL_TRIALS trial_result · 2022-08-11
  Clinical Trial Update: Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer [Phase 2]

  Phase 2 clinical trial update evaluating intraperitoneal chemotherapy guided by detection of DNA in peritoneal lavage fluid for gastric canc…

• CLINICAL_TRIALS trial_result · 2022-08-04
  Clinical Trial Update: Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer [Phase 1, Phase 2]

  This ClinicalTrials.gov update reports results from a Phase 1/2 study evaluating the combination of margetuximab and pembrolizumab in advanc…

• CLINICAL_TRIALS trial_result · 2022-07-20
  Clinical Trial Update: A Prospective, Single Center Clinical Study of Toripalimab Combined With FLOT Regimen for Perioperative Treatment of PD-L1 Positive Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GEJ) [Phase 2]

  Phase 2 clinical trial evaluating toripalimab plus FLOT as perioperative treatment for PD-L1 positive locally advanced resectable gastric ca…

• CLINICAL_TRIALS trial_result · 2022-07-08
  Clinical Trial Update: A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer [Phase 3]

  Phase 3 trial evaluating rivoceranib plus best supportive care versus placebo plus best supportive care in gastric cancer; trial completed w…

• CLINICAL_TRIALS trial_result · 2022-07-08
  Clinical Trial Update: Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical Study [Phase 2]

  A single-arm Phase 2 clinical trial evaluating camrelizumab with intraperitoneal nab-paclitaxel, intravenous chemotherapy, and S-1 for advan…

• CLINICAL_TRIALS trial_result · 2022-07-08
  Clinical Trial Update: Intraperitoneal Aerosol Chemotherapy in Gastric Cancer [Phase 2]

  Phase 2 trial update on intraperitoneal aerosol chemotherapy for gastric cancer (completed).

• CLINICAL_TRIALS trial_result · 2022-07-01
  Clinical Trial Update: A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer [Phase 4]

  Phase 4 trial update for apatinib tablets in advanced or metastatic gastric cancer, status completed.

• CLINICAL_TRIALS trial_result · 2022-06-28
  Clinical Trial Update: Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer [Phase 3]

  Phase 3 efficacy trial comparing nivolumab plus ipilimumab or nivolumab plus chemotherapy against standard chemotherapy in gastric cancer an…

• CLINICAL_TRIALS trial_result · 2022-06-27
  Clinical Trial Update: Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations [Phase 2]

  Phase 2 trial evaluating Infigratinib in gastric cancer or GEJ adenocarcinoma with FGFR2 amplification or other FGFR alterations; current st…

• CLINICAL_TRIALS trial_result · 2022-06-24
  Clinical Trial Update: Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells [Phase 2]

  Phase 2 study evaluating nab-paclitaxel plus camrelizumab and S-1 conversion therapy for gastric cancer with positive exfoliative cancer cel…

• CLINICAL_TRIALS trial_result · 2022-06-15
  Clinical Trial Update: As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to Biomarkers [Phase 2]

  Phase 2a trial evaluating safety and efficacy of Vactosertib with paclitaxel and ramucirumab as a second-line treatment for metastatic gastr…

• CLINICAL_TRIALS trial_result · 2022-06-15
  Clinical Trial Update: Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment [Phase 1, Phase 2]

  Phase Ib/Phase II single-arm studies evaluating AZD6094 (Volitinib) with Docetaxel in solid cancers, and in advanced gastric adenocarcinoma …

• CLINICAL_TRIALS trial_result · 2022-06-06
  Clinical Trial Update: A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer [Phase 3]

  Phase 3 clinical trial evaluating HLX10 plus chemotherapy versus placebo plus chemotherapy for neoadjuvant/adjuvant treatment of gastric can…

• CLINICAL_TRIALS trial_result · 2022-06-02
  Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer [Phase 2]

  Phase 2 study investigating the safety and efficacy of Max-40279-01 in advanced gastric cancer or gastroesophageal junction cancer.